Skip to content

COVID-19 Surveillance and Exposure Testing in School Communities

Coronavirus Disease 2019 (COVID-19) Surveillance and Exposure Testing in School Communities

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04831866
Enrollment
4000
Registered
2021-04-05
Start date
2021-04-26
Completion date
2022-01-31
Last updated
2022-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

This is a prospective, observational study of COVID-19 surveillance and exposure testing in school communities. Participating school communities are providing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests to students and staff at their schools per school, local, and national guidelines. This study will combine data received from the schools with data collected directly from participants to guide analysis of the co-primary objectives. Participants will be grouped into two different cohorts, depending on each school's SARS-CoV-2 test administration practices. Surveillance Cohort: Schools participating in this cohort will be performing surveillance testing weekly on approximately 10-20% of students and 100% of staff. Exposure Cohort: Schools participating in this cohort will be performing exposure testing on students and staff who have been identified as having close contact with school members diagnosed with SARS-CoV-2 infection.

Interventions

None listed

Sponsors

Duke University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Data from all participating school communities will be included in this study (no inclusion/

Exclusion criteria

will be assessed).

Design outcomes

Primary

MeasureTime frameDescription
Evaluate secondary transmission/prevalence of SARS-CoV-2 in Kindergarten through 12th grade schools in the Surveillance Cohort.2 yearsProportion of students/staff with positive SARS-CoV-2 test identified by surveillance testing.
Evaluate secondary transmission/prevalence of SARS-CoV-2 in Kindergarten through 12th grade schools in the Exposure Cohort.2 yearsProportion of students/staff with positive SARS-CoV-2 test following within-school exposure.
Describe return to school outcomes in Kindergarten through 12th grade schools in Surveillance Cohort.2 yearsProportion of students who return to in-person education in Fall 2021, Spring 2022, and Fall 2022 from participating schools conducting surveillance testing compared to districts without testing.
Describe return to school outcomes in Kindergarten through 12th grade schools in Exposure Cohort.2 yearsMean time to return-to-school after SARS-CoV-2 exposure in the month after initiation of the school-provided testing program compared to the month prior to initiation of the school-provided testing program.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026